May 2018

– Positive unanimous vote at Epidiolex® (cannabidiol) FDA Advisory Committee meeting –– NDA PDUFA goal date scheduled for June 27, 2018 –– Conference call today at 4:30 p.m. EST – LONDON and CARLSBAD, Calif., May 08, 2018 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (NASDAQ:GWPH) (GW, the Company or the Group), a biopharmaceutical company focused on […]

Traumatic brain injury (TBI) is one of the leading causes of death worldwide in individuals under the age of 45. Triggered by concussions from car accidents, falls, violent contact sports, explosives or by gunshot and stab wounds, TBI affects 1.7 million Americans annually. It is the most commonly identified cause of epilepsy among adults. The social and economic […]

On this auspicious April 20th, three developments in the world of cannabis regulation caught our attention. The first is the unanimous recommendation by a panel of outside advisers to FDA in favor of approving Epidiolex, an epilepsy drug manufactured by GW Pharmaceuticals. The active ingredient in Epidiolex is cannabidiol (CBD), which is a chemical found […]

Dravet syndrome (DS), also known as epilepsy with polymorphic seizures and polymorphic epilepsy in infancy (PMEI), is a severe and rare genetic dysfunction of the brain (epileptic encephalopathy). It usually begins in first year of life and remains throughout lifetime. Children suffering from dravet syndrome suffer from different type of seizures namely, myoclonic seizures, tonic-clonic […]

What does the cannabis industry have for Plumas? Companies in other parts of the country and world are finding new uses and new products using the  ancient cannabis plant. All signs point to legalization being a good thing: the cannabis industry is donning the cloak of professionalism and innovation. There are investors, business plans, clinical […]

Dravet syndrome (DS), also known as epilepsy with polymorphic seizures and polymorphic epilepsy in infancy (PMEI), is a severe and rare genetic dysfunction of the brain (epileptic encephalopathy). It usually begins in first year of life and remains throughout lifetime. Children suffering from dravet syndrome suffer from different type of seizures namely, myoclonic seizures, tonic-clonic […]

By Winona LaDuke Tribal hemp growers have planted the seeds of a new economy and an innovative and holistic approach to many challenges in our territories. This spring, gathering first on the White Earth reservation and then in Colorado, tribal “hempsters” have joined an international renaissance of the plant which once clothed much of Europe […]

Buffy, the seven-year-old golden retriever/border collie mix rescue dog, just didn’t seem like herself. Her owner, Marge Holman, remembers Buffy being stiff, lethargic, and walking with little ‘hiccups,’ “It wasn’t bothering her but it started bothering me,” said Holman, hugging her puppy at the Essex Animal Clinic.  “I wanted to jump on top of it and […]

Active-Investors.com has just released a free research report on INSYS Therapeutics, Inc. (NASDAQ: INSY) (“INSYS”). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=INSY as the Company’s latest news hit the wire. On April 27, 2018, the Company announced that it has initiated a Phase-2 […]